Assiut university hospital
Asyut, Assiut, Egypt
Location status: Recruiting
Recruiting
NCT Number: NCT06614114
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
Albumin bilirubin index as a predictor of outcome of variceal bleeding
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year–80 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
This study is to clarify the predictive value of albumin bilirubin index for recurrent bleeding within 3 month after endoscopic treatment in patients with cirrhosis and EGVB
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age between 18-80 years old
Exclusion criteria
- Hcc Hematological disease
Treatment and study plan
Primary outcomes
-
prevelence of Variceal bleeding in high alb/bill index
Time frame: 6 months
Prevelence of bleeding in patient with cirrhosis
Study contacts
Contact information is provided by the study sponsor or research team.
Ahmed M.Ashmawy
CONTACT
Heba Sayed Zaki
CONTACT
Sponsors and collaborators
Lead sponsor
Assiut University
Other
Registry information
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2025
- First posted
- Sep 26, 2024
- Registry last updated
- Sep 26, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.